2019
DOI: 10.1016/j.addr.2018.08.010
|View full text |Cite
|
Sign up to set email alerts
|

Physically-triggered nanosystems based on two-dimensional materials for cancer theranostics

Abstract: There is an increasing demand to develop effective methods for treating malignant diseases to improve healthcare in our society. Stimuli-responsive nanosystems, which can respond to internal or external stimuli are promising in cancer therapy and diagnosis due to their functionality and versatility. As a newly emerging class of nanomaterials, two-dimensional (2D) nanomaterials have attracted huge interest in many different fields including biomedicine due to their unique physical and chemical properties. In th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
50
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 59 publications
(53 citation statements)
references
References 164 publications
1
50
0
Order By: Relevance
“…Currently, multiple combinations of various therapeutic and diagnostic modalities are adopted to achieve a theranostic effect (Orecchioni et al, 2015; Ji et al, 2019), and can be further improved and expanded thanks to the development of NM-based theranostic nanoplatforms. Among 2D NMs suitable for this purpose, graphene and graphene-based materials (GBMs), including few layer graphene (FLG), graphene oxide (GO), reduced graphene oxide (rGO), nano-graphene oxide (NGO), and graphene quantum dots (GQDs), bring the technological innovations needed to the current societal and industrial challenges (Boukhvalov and Katsnelson, 2008; Park and Ruoff, 2009; Gao et al, 2010; Kuila et al, 2012; Mao et al, 2012; James and Tour, 2013; Quintana et al, 2013; Yang et al, 2013a; Roppolo et al, 2014; Sechi et al, 2014; Servant et al, 2014; Kim et al, 2016; Shin et al, 2016; McManus et al, 2017; Park et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, multiple combinations of various therapeutic and diagnostic modalities are adopted to achieve a theranostic effect (Orecchioni et al, 2015; Ji et al, 2019), and can be further improved and expanded thanks to the development of NM-based theranostic nanoplatforms. Among 2D NMs suitable for this purpose, graphene and graphene-based materials (GBMs), including few layer graphene (FLG), graphene oxide (GO), reduced graphene oxide (rGO), nano-graphene oxide (NGO), and graphene quantum dots (GQDs), bring the technological innovations needed to the current societal and industrial challenges (Boukhvalov and Katsnelson, 2008; Park and Ruoff, 2009; Gao et al, 2010; Kuila et al, 2012; Mao et al, 2012; James and Tour, 2013; Quintana et al, 2013; Yang et al, 2013a; Roppolo et al, 2014; Sechi et al, 2014; Servant et al, 2014; Kim et al, 2016; Shin et al, 2016; McManus et al, 2017; Park et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Graphene oxide (GO) has been extensively investigated in many fields, in particular in nanomedicine because of its excellent aqueous processability, amphiphilicity and the possibility of surface functionalization . In its reduced form, it displays thermal and electrical conductivity that can be exploited for the development of biosensors .…”
Section: Introductionmentioning
confidence: 99%
“…2D nanomaterials for drug delivery systems have been extensively studied due to their high specific surface area and unique surface chemistry functions. 64,65 The surface of BP is negatively charged and can bond with positively charge drugs. 66 Various functional biomolecules and nanoparticles can be adsorbed onto the surface of BP nanomaterials.…”
Section: Drug-loading Capacitymentioning
confidence: 99%